Piramal Pharma Solutions

Home
United States
Riverview, MI
Piramal Pharma Solutions

PPS is a CDMO offering end-to-end development and manufacturing solutions across the drug lifecycle.

We serve our clients through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies, Commercial supply of APIs, and Finished dosage forms. We also offer specialized services like the development and manufactur

e of Highly Potent APIs and Antibody Drug Conjugation. Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide. For more information and updates, please visit: www.piramalpharmasolutions.com

05/04/2026

Controlling nitrosamine formation starts with detecting inorganic nitrite at the earliest stage. Ion Chromatography is one of the most reliable tools to quantify nitrite levels in excipients, APIs, drug products, and even water.

At PPDS Ahmedabad, we bring deep analytical expertise to help you detect, understand, and mitigate nitrosamine-related risks with precision.

Why IC matters:
• High sensitivity & specificity — Detects ions at low concentrations with accuracy.
• Low detection limits — Ideal for trace-level nitrite analysis.
• Robust & reliable — Consistent performance across complex matrices.

Why partner with us?
• Proven hands-on expertise in Ion Chromatography.
• End-to-end support: method development, verification & testing.
• Science-driven guidance to strengthen risk assessment and regulatory preparedness.

Make smarter, faster decisions with data you can trust.
Strengthen your nitrosamine control strategy from day one.

04/30/2026

From development to delivery, sterile injectables require uncompromising precision.

With advanced aseptic technologies and deep manufacturing expertise, Piramal Pharma Solutions supports the safe production of complex therapies across clinical and commercial stages.

Head to our blog to learn more about how sterile fill/finish plays a vital role in delivering quality and reliability in modern medicine
https://lnkd.in/dsMzu9QS

04/29/2026

Piramal Pharma Solutions brings together global CDMO scale and scientific teams to deliver complete solutions from API development to commercial packaging, accelerating timelines and complex therapies to market.

With integrated capabilities across discovery, development, and manufacturing, we ensure quality and efficiency so you can focus on innovation.

04/27/2026

We continue to build a world-class business development team at Piramal Pharma Solutions as we advance our long-term growth ambitions and deepen the value we create for our partners.

We’re pleased to welcome Gregory Judge as Director, Business Development, within our European team. In this role, Greg will focus on expanding strategic partnerships for our large-scale molecule biologics business across Europe.

Greg brings extensive experience spanning biologics, cell and gene therapy, and advanced modalities. Most recently at Thermo Fisher Scientific, he led business development across EMEA, driving new opportunities and significantly expanding the mRNA and advanced therapies pipeline.

Prior to this, Greg held leadership roles at Merck Life Science, Catalent Biologics, and WuXi AppTec, where he consistently drove commercial growth, built strategic partnerships, and supported licensing and M&A initiatives.

Greg holds a Master’s degree in Drug Discovery & Development from Drexel University College of Medicine.

We’re excited to have Greg on board and look forward to the impact he will make for our clients and our teams across Europe.

04/27/2026

Log P and pKa are key physicochemical parameters that shape a drug’s ADMET profile—directly influencing absorption, permeability, solubility, stability, and overall bioavailability.

Log P helps predict:
• Permeability & absorption.
• Solubility balance.
• Bioavailability.
• Formulation behavior.
• Toxicity & distribution.

pKa helps determine:
• Solubility across pH ranges.
• Absorption site in the GI tract.
• Salt selection.
• Stability & compatibility in formulations.

Why Partner With Us?

We provide accurate, regulatory-aligned Log P and pKa determination using globally accepted OECD guidelines:

• Log P: OECD TG 107 (Shake Flask), TG 117 (HPLC), TG 112.
• pKa: Potentiometric titration & UV-spectroscopic methods.
• Science-backed methodologies and advanced analytical tools.

Get reliable data that strengthens development decisions, supports regulatory submissions, and accelerates your molecule’s journey.

04/27/2026

Antibody-drug conjugates (ADCs) are redefining how cancer is treated, combining targeted precision with powerful therapeutics.

From complex development processes to highly controlled manufacturing, bringing ADCs to life requires deep scientific expertise and integrated capabilities and at Piramal Pharma Solutions, our end-to-end approach enables seamless ADC development, helping accelerate the journey from discovery to commercialization.

Read our blog to explore how ADCs are transforming oncology and what it takes to deliver them successfully.

https://lnkd.in/dfQcDcvE

04/23/2026

The energy at our booth at CPhI Japan is in full swing!

Great to see so many engaging conversations, insightful meetings, and new connections taking shape.

Our team is having some truly meaningful discussions around advancing complex drug development and manufacturing solutions.

If you’re at the event, come experience the buzz firsthand.

Visit us at Booth 1-C32. We’d love to connect.

04/23/2026

Our booth has been buzzing with insightful conversations, new connections, and meaningful discussions around advancing customer projects. Great to see such strong engagement from across the industry.

If you’re here, don’t miss the chance to connect with our team and stop by Booth No. 1C-32. We’d love to continue the conversation.

04/21/2026

All smiles at CPhI Japan!

Our team is here, energized and ready to connect - bringing together expertise from across regions to support our partners at every stage of the drug development journey.

It’s been fantastic meeting so many of you already, looking forward to more meaningful conversations over the next couple of days.

Come say hello at our booth!
Booth no: 1C-32

04/20/2026

Why Enteral Feeding Tube In-Vitro Studies Matter?
It’s not just conducting the study—accurate documentation is essential to prove your product is suitable for NG and G-tube administration.

What Needs to Be Done Right:
• Follow FDA guidance precisely.
• Verify labeling requirements.
• Document tube type, size, brand & syringe specifications.
• Record pH and administration steps.
• Inspect tubing/syringes for aggregation or adherence (with photos/videos).
• Clearly explain comparative testing & recovery calculations.

Key Benefits:
✔ Confirms compatibility.
✔ Optimizes formulation performance.
✔ Reduces patient and product risk.

Why Partner With Us?
With proven expertise and strong scientific guidance, we help you make confident, compliant decisions—saving time, cost, and avoiding regulatory setbacks.

Make your drug product NG/G-tube ready with data you can trust.

04/17/2026

Integrated drug development is transforming how therapies are brought to market by aligning every stage under a single, cohesive strategy. As complexity increases, this approach improves efficiency, reduces handoffs, and ensures continuity across the lifecycle.

By combining development and manufacturing within an integrated framework, organizations can accelerate timelines, enhance collaboration, and drive more reliable outcomes.

At Piramal Pharma Solutions, our global network and integrated program management enable seamless transitions and consistent ex*****on at every stage.

Head to our blog to know more about our integrated approach:
https://www.piramalpharmasolutions.com/resources/blogs/integrated-drug-development

04/15/2026

The countdown is on!
Just 1 week to go for CPhI Japan.

Join us at Booth 1C-32 and connect with our global team, including senior leadership, our Country Manager Teppei for Japan & Korea, and our ADC expert Conor Barry from our Science Collective.

From payload-linker development and bioconjugation to clinical-to-commercial scale-up, explore how our integrated capabilities across our Grangemouth, Scotland and Lexington sites support complex ADC programs end to end.

Whether you're at an early stage or advancing toward commercialization, our team is ready to discuss how we can support your next step.

🗓️ 21-23rd April, 2026
📍 East Halls 1, 2 & 3, Tokyo Big Sight, Tokyo, Japan

Address

18655 Krause Street
Riverview, MI
48193

Website

https://www.piramalpharmasolutions.com/

Alerts

Be the first to know and let us send you an email when Piramal Pharma Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Riverview?

Piramal Pharma Solutions

05/04/2026

04/30/2026

04/29/2026

04/27/2026

04/27/2026

04/27/2026

04/23/2026

04/23/2026

04/21/2026

04/20/2026

04/17/2026

04/15/2026

Address

Website

Alerts

Shortcuts

Share

Category